buthionine sulfoximine has been researched along with Granulocytic Leukemia, Chronic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandyopadhyay, S; Biswas, N; Chatterjee, S; Chaudhuri, J; Chaudhuri, U; Chowdhury, AA; Jaisankar, P; Mahato, SK; Manna, A | 1 |
| Ferreira, AC; Klumb, CE; Kwee, JK; Luque, DG; Maia, RC; Silva, KL; Vasconcelos, FC | 1 |
| Kneifel, C; Lösler, S; Rojewski, MT; Schlief, S; Schrezenmeier, H; Thiel, E | 1 |
| Adjei, AA; Bone, N; Bruzek, LM; Chandra, J; Hackbarth, J; Karp, JE; Kaufmann, SH; Kay, NE; Le, S; Loegering, D; Narayanan, VL; Sausville, EA; Tefferi, A | 1 |
| Härtel, N; Hehlmann, R; Hochhaus, A; Konig, H; La Rosée, P; Lorentz, C; Melo, JV; Schatz, M; Schultheis, B | 1 |
| Chigurupati, R; Frischer, H; Kennedy, EJ; Sivarajan, M | 1 |
| Ballard, K; Jollow, DJ; Oatis, JE; Peters, RH; Stuart, RK | 1 |
7 other study(ies) available for buthionine sulfoximine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway.
Topics: Animals; Apoptosis; Apoptosis Inducing Factor; Blotting, Western; Buthionine Sulfoximine; Cell Line, Tumor; Chlorocebus aethiops; Drug Synergism; Eugenol; Extracellular Signal-Regulated MAP Kinases; Glutathione; Hep G2 Cells; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Microscopy, Confocal; NIH 3T3 Cells; Nitric Oxide; Nitric Oxide Synthase Type II; Reactive Oxygen Species; Signal Transduction; U937 Cells; Vero Cells | 2013 |
Modulation of reactive oxygen species by antioxidants in chronic myeloid leukemia cells enhances imatinib sensitivity through survivin downregulation.
Topics: Amitrole; Antineoplastic Agents; Antioxidants; Benzamides; Buthionine Sulfoximine; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Imatinib Mesylate; Inhibitor of Apoptosis Proteins; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Microtubule-Associated Proteins; Neoplasm Proteins; Piperazines; Pyrimidines; Reactive Oxygen Species; Survivin | 2008 |
Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
Topics: Antimony; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Caspase Inhibitors; Caspases; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Glutathione; HL-60 Cells; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, T-Cell; Membrane Potential, Mitochondrial; Neoplasm Proteins; Oxidation-Reduction; Oxides | 2009 |
Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells.
Topics: Acetylcysteine; Adamantane; Antioxidants; Apoptosis; Buthionine Sulfoximine; DNA Damage; DNA, Neoplasm; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Glutathione; Humans; Hydroquinones; K562 Cells; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Neoplasm Proteins; Neoplastic Stem Cells; Quinones; Reactive Oxygen Species; Tumor Stem Cell Assay; Tyrphostins | 2003 |
Enhanced Bcr-Abl-specific antileukemic activity of arsenic trioxide (Trisenox) through glutathione-depletion in imatinib-resistant cells.
Topics: Arsenic Trioxide; Arsenicals; Benzamides; Buthionine Sulfoximine; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Fusion Proteins, bcr-abl; Glutathione; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oxides; Piperazines; Pyrimidines | 2007 |
Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.
Topics: Buthionine Sulfoximine; Carmustine; Cell Cycle; Cell Division; Cell Line; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Drug; Glutathione; Glutathione Reductase; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methionine Sulfoximine; Tumor Cells, Cultured | 1993 |
Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells.
Topics: Antimetabolites; Buthionine Sulfoximine; Cell Line; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methionine Sulfoximine; Sulfhydryl Compounds; Tumor Cells, Cultured | 1990 |